Pancreatic Cancer Research Program
This grant funds innovative research to improve early detection, care, and treatment of pancreatic cancer, focusing on scientific advances in biology, biomarkers, risk, and new therapies.
Funder: Military Health System Research Program
Due Dates (Anticipated): June 2026: Letter of Intent (Focused Pilot Award) | June 2026: Preproposal (Idea Development & Translational Research Partnership Awards) | September 2026: Full Application (by invitation)
Funding Amounts: Focused Pilot: up to $300,000 (2 yrs) | Idea Development: up to $700,000 (3 yrs; up to $950,000 with Early-Career PI) | Translational Research Partnership: up to $1.1M (3 yrs)
Summary: Supports innovative, high-impact research to advance detection, care, and treatment of pancreatic cancer.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to official announcement.
Description
The Pancreatic Cancer Research Program (PCARP), managed by the Congressionally Directed Medical Research Programs (CDMRP) under the Defense Health Agency, funds research of exceptional scientific merit and innovation targeting pancreatic cancer. The program aims to advance understanding and develop solutions in early detection, risk identification, supportive care, healthcare access, metabolic disruptions, tumor biology, biomarker discovery, and new therapeutic approaches. PCARP is committed to supporting research that can significantly improve outcomes and quality of life for individuals affected by pancreatic cancer, including Service members, Veterans, and the broader public.
